Application Sponsors
ANDA 213279 | AUROBINDO PHARMA LTD | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 1MG/ML | 0 | NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2021-01-14 | STANDARD |
LABELING; Labeling | SUPPL | 2 | AP | 2021-11-17 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
AUROBINDO PHARMA LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 213279
[companyName] => AUROBINDO PHARMA LTD
[docInserts] => ["",""]
[products] => [{"drugName":"NALOXONE HYDROCHLORIDE","activeIngredients":"NALOXONE HYDROCHLORIDE","strength":"1MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"01\/14\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2021-01-14
)
)